Olinger Margaret 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Jan 10, 2022
Insider Transaction Report
Form 4
Olinger Margaret
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-06+127,500→ 127,500 totalExercise: $19.00Exp: 2032-01-06→ Common Stock (127,500 underlying) - Award
Common Stock
2022-01-06+28,333→ 209,916 total - Purchase
Common Stock
2022-01-06$19.00/sh+6,842$129,998→ 216,758 total
Footnotes (2)
- [F1]The reported transaction involves the Reporting Person's receipt of a restricted stock unit award (a "RSU"). The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first anniversary of the date of the grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.
- [F2]1/4 of the shares subject to the option shall vest and become exercisable on the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date.